Stability of the dexamethasone suppression test in borderline personality disorder with and without comorbid PTSD: A one-year follow-up study

Journal of Clinical Psychology

Volumn 63, Issue 9, 2007, Pages 843-850

  Wingenfeld, Katja ^a   Lange, Wolfgang ^a   Wulff, Hella ^a   Berea, Christina ^a   Beblo, Thomas ^a   Saavedra, Anamaria Silva ^a   Mensebach, Christoph ^b   Driessen, Martin ^b,c  

^a EVANGELISCHES KRANKENHAUS   (Germany)

^b BIELEFELD UNIVERSITY   (Germany)

^c University of Schleswig Holstein   (Germany)

Author keywords

Borderline personality disorder; Cortisol; Dexamethasone suppression test; Posttraumatic stress disorder; Stability

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ADULT; ARTICLE; BORDERLINE STATE; CLINICAL ARTICLE; COMORBIDITY; DEXAMETHASONE SUPPRESSION TEST; ENDOCRINE FUNCTION TEST; FEEDBACK SYSTEM; FEMALE; FOLLOW UP; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MENSTRUAL CYCLE; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGIC ASSESSMENT; STATISTICAL ANALYSIS;

ADULT; BORDERLINE PERSONALITY DISORDER; CIRCADIAN RHYTHM; COMORBIDITY; DEXAMETHASONE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LONGITUDINAL STUDIES; PITUITARY-ADRENAL SYSTEM; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC;

EID: 34548806323     PISSN: 00219762     EISSN: 10974679     Source Type: Journal    
DOI: 10.1002/jclp.20396     Document Type: Article

References (36)

1. Baxter, L., Edell, W., Gerner, R., Fairbanks, L., & Gwirtsman, H. (1984). Dexamethasone suppression test and Axis I diagnoses of inpatients with DSM-III borderline personality disorder. Journal of Clinical Psychiatry, 45, 150-153.
2. Beeber, A. R., Kline, M. D., Pies, R. W., & Manring, J. M., Jr. (1984). Dexamethasone suppression test in hospitalized depressed patients with borderline personality disorder. Journal of Nervous and Mental Disease, 172, 301-303.
3. Carroll, B. J. (1984). Dexamethasone suppression test for depression. Advances in Biochemistry and Psychopharmacology, 39, 179-188.
4. Charles, G., Wilmotte, J., Quenon, M., & Mendlewicz, J. (1982). Reproducibility of the dexamethasone suppression test in depression. Biological Psychiatry, 17, 845-848.
5. Franke, G. (1995). Die Symptom-Checkliste von Derogatis-Deutsche Version. Göttingen: Beltz Test GmbH.
6. Fydrich, T., Renneberg, B., Schmitz, B., & Wittchen, H. U. (1997). Strukturierte Klinisches Interview für DSM-IV. Achse II: Persönlichkeitsstörungen, SKID-II. Göttingen: Hogrefe & Huber.
7. Grossman, R., Yehuda, R., New, A., Schmeidler, J., Silverman, J., Mitropoulou, V., et al. (2003). Dexamethasone suppression test findings in subjects with personality disorders: associations with posttraumatic stress disorder and major depression. American Journal of Psychiatry, 160, 1291-1298.
8. Grossman, R., Yehuda, R., & Siever, L. (1997). The dexamethasone suppression test and glucocorticoid receptors in borderline personality disorder. Annals of New York Academy of Sciences, 821, 459-464.
9. Heber, R., Kellner, M., & Yehuda, R. (2002). Salivary cortisol levels and the cortisol response to dexamethasone before and after EMDR: A case report. Journal of Clinical Psychology, 58, 1521-1530.
10. Holsboer, F., Liebl, R., & Hofschuster, E. (1982). Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement. Journal of Affective Disorders, 4, 93-101.
11. Holsboer, F., Wiedemann, K., Gerken, A., & Boll, E. (1986). The plasma dexamethasone variable in depression: Test-retest studies and early biophase kinetics. Psychiatry Research, 17, 97-103.
12. Huizenga, N. A., Koper, J. W., de Lange, P., Pols, H. A., Stolk, R. P., Grobbee, D. E., et al. (1998). Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamus-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. Journal of Clinical Endocrinology and Metabolism, 83, 47-54.
13. Ising, M., Kunzel, H. E., Binder, E. B., Nickel, T., Modell, S., & Holsboer, F. (2005). The combined dexamethasone/CRH test as a potential surrogate marker in depression. Progress in Neurpsychopharmacology and Biological Psychiatry, 29, 1085-1093.
14. Kellner, M., Baker, D. G., Yassouridis, A., Bettinger, S., Otte, C., Naber, D., et al. (2002). Mineralocorticoid receptor function in patients with posttraumatic stress disorder. American Journal of Psychiatry, 159, 1938-1940.
15. Kellner, M., Yehuda, R., Arlt, J., & Wiedemann, K. (2002). Longitudinal course of salivary cortisol in post-traumatic stress disorder. Acta Psychiatrica Scandinavica, 105, 153-155; discussion 155-156.
16. Kirschbaum, C., Kudielka, B. M., Gaab, J., Schommer, N. C., & Hellhammer, D. H. (1999). Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosomatic Medicine, 61, 154-162.
17. Krishnan, K. R., Davidson, J. R., Rayasam, K., & Shope, F. (1984). The dexamethasone suppression test in borderline personality disorder. Biological Psychiatry, 19, 1149-1153.
18. Lahmeyer, H. W., Val, E., Gaviria, F. M., Prasad, R. B., Pandey, G. N., Rodgers, P., et al. (1988). EEG sleep, lithium transport, dexamethasone suppression, and monoamine oxidase activity in borderline personality disorder. Psychiatry Research, 25, 19-30.
19. Lange, W., Wulff, H., Berea, C., Beblo, T., Saavedra, A. S., Mensebach, C., et al. (2005). Dexamethasone suppression test in borderline personality disorder-effects of posttraumatic stress disorder. Psychoneuroendocrinology, 30, 919-923.
20. Linehan, M. (1996). Dialektisch behaviourale therapie (DBT) der borderline. PErsönlichkeitsstörung. München: CIP Medien.
21. Maercker, A., & Schützwohl, M. (1998). Erfassung von psychischen Belastungsfolgen: Die Impact of Event Skala-revidierte Version (IES-R). Diagnostica, 3, 130-141.
22. Maes, M., Lin, A., Bonaccorso, S., van Hunsel, F., Van Gastel, A., Delmeire, L., et al. (1998). Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatrica Scandinavica, 98, 328-335.
23. McFarlane, A. C. (1997). The prevalence and longitudinal course of PTSD. Implications for the neurobiological models of PTSD. Annals of New York Academy of Sciences, 821, 10-23.
24. Otte, C., Lenoci, M., Metzler, T., Yehuda, R., Marmar, C. R., & Neylan, T. C. (2005). Hypothalamic-pituitary-adrenal axis activity and sleep in posttraumatic stress disorder. Neuropsychopharmacology, 30, 1173-1180.
25. Resnick, H. S., Yehuda, R., Pitman, R. K., & Foy, D. W. (1995). Effect of previous trauma on acute plasma cortisol level following rape. American Journal of Psychiatry, 152, 1675-1677.
26. Soloff, P. H., George, A., & Nathan, R. S. (1982). The dexamethasone suppression test in patients with borderline personality disorders. American Journal of Psychiatry, 139, 1621-1623.
27. Sundin, E. C., & Horowitz, M. J. (2002). Impact of Event Scale: Psychometric properties. British Journal of Psychiatry, 180, 205-209.
28. Wittchen, H. U., Zaudig, M., & Fydrich, T. (1997). Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen, SKID-I. Göttingen: Hogrefe & Huber.
29. Yehuda, R. (2002). Current status of cortisol findings in post-traumatic stress disorder. Psychiatric Clinics of North America, 25, 341-368, vii.
30. Yehuda, R., Golier, J. A., Halligan, S. L., Meaney, M., & Bierer, L. M. (2004). The ACTH response to dexamethasone in PTSD. American Journal of Psychiatry, 161, 1397-1403.
31. Yehuda, R., Halligan, S. L., Golier, J. A., Grossman, R., & Bierer, L. M. (2004). Effects of trauma exposure on the cortisol response to dexamethasone administration in PTSD and major depressive disorder. Psychoneuroendocrinology, 29, 389-404.
32. Yehuda, R., Halligan, S. L., Grossman, R., Golier, J. A., & Wong, C. (2002). The cortisol and glucocorticoid receptor response to low dose dexamethasone administration in aging combat veterans and holocaust survivors with and without posttraumatic stress disorder. Biological Psychiatry, 52, 393-403.
33. Yehuda, R., Kahana, B., Binder-Brynes, K., Southwick, S. M., Mason, J. W., & Giller, E. L. (1995). Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder. American Journal of Psychiatry, 152, 982-986.
34. Yehuda, R., Southwick, S. M., Krystal, J. H., Bremner, D., Charney, D. S., & Mason, J. W. (1993). Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. American Journal of Psychiatry, 150, 83-86.
35. Yerevanian, B. I., Anderson, J. L., & Milanese, E. (1985). Effect of weekly testing on dexamethasone suppression test results in normal subjects. Psychiatry Research, 14, 209-213.
36. Zanarini, M. C., Frankenburg, F. R., Hennen, J., & Silk, K. R. (2003). The longitudinal course of borderline psychopathology: 6-year prospective follow-up of the phenomenology of borderline personality disorder. American Journal of Psychiatry, 160, 274-283.